Before making a move on any particular stock, readers often pay close attention to support and resistance markers. The last reported price for shares of Zimmer Biomet Holdings, Inc. (ZBH) was $125.92. Currently, the 1st Resistance Point for this stock is $126.96, with a 2nd Resistance Point sitting at $128.01. Meanwhile, this company’s stock has a 1st Support Level at $123.85 and a 2nd Support Level at $121.79. Zimmer Biomet Holdings, Inc. (ZBH) stock has gained $4.31, or 3.54%, in the past five days. In the last full month, these shares have gained $2.27, or 1.84%. In the past three months, this stock’s price has risen by $16.93, or 15.53%. This year-to-date, Zimmer Biomet Holdings, Inc. (ZBH) shares have gained $22.20, or 21.40%.
Analyzing price projection indicators is a helpful way to determine whether a potential stock buy is a wise choice for profits in the short term, medium term, and long term. For Zimmer Biomet Holdings, Inc. (ZBH) stock, 100% of short-term indicators suggest that these shares are a “ Buy .” Meanwhile, 75% of medium-term indicators point to this stock being a “ Buy .” Looking further ahead, 67% of long-term indicators suggest that this stock is a “ Buy .”
With 204,433 K shares outstanding, this company currently has a market capitalization of $25,742,200K. Zimmer Biomet Holdings, Inc. (ZBH) generates $7,933 M in annual sales, amounting to annual net income of -$379,200 K. This stock has generated a 1-Year Total Return of 8.63%, a 3-Year Total Return of 20.49%, and a 5-year Total Return of 34.62%. This stock’s 5-Year Dividend Growth is 20.00%, with its most recent dividend valued at $0.240 per share on 12/27/18. Its Annual Dividend Yield is 0.76%, and its Annual Dividend Rate is 0.96.
In the most recently-reported fiscal quarter, which ended in Dec-18, Zimmer Biomet Holdings, Inc. (ZBH) reported earnings of $2.18 per share. Wall Street analysts, on average, were expecting the company to report earnings of $2.17 per share, representing a 0.01 difference and 0.34% surprise. In the previous quarter ending in Sep-18, the reported earnings of $1.63 represented a 0.03 difference from the consensus estimate calling for $1.60 per share, which was a 1.56% surprise.
For the current fiscal quarter, which is set to end in 03/2019, the average earnings estimate is $1.87 per share. This estimate came from a total of 15 Wall Street Analysts. Of those market experts, the high estimate was $1.95 and the low estimate was $1.83. In the year-ago quarter, Zimmer Biomet Holdings, Inc. (ZBH) generated per-share earnings of $1.91. If the analysts are correct about the current quarter’s earnings, the growth will be -2.09% .
Turning our focus now to insider trading activity, there have been 20 purchases (35,047 shares in total) and 2 sale (4,052 shares in total) in the last 3 months. In the last 6 months, there have been 21 insider buys amounting to 65,147 shares and 3 insider sales amounting to 34,152 shares. In the past full year, 26 insider purchases were made (involving 82,418 shares) and 11 insider sell-offs equivalent to 49,374 shares.
Moving onto liquidity, Zimmer Biomet Holdings, Inc. (ZBH) has a Current Ratio of 1.83, a Quick Ratio of 0.90 and a Cash Ratio of 0.22. Looking at this company’s capital structure, its Total Debt to Total Equity is 79.30, its Total Debt to Total Capital is 44.23, and its Total Debt to Total Assets is now 37.05. Looking even further ahead into the future, its Long-Term Debt to Equity is 74.65 and its Long-Term Debt to Total Capital is 41.63.